RAG-17 therapy slowed functional decline and stabilized or improved breathing in people with ALS who carry mutations in the SOD1 gene.

Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...

Eric Dane's ALS diagnosis has raised awareness about Lou Gehrig's disease, its symptoms, causes, and how other celebrities ...

The company expects early cohort data this year from the trial assessing the calpain-2-targeted antisense oligonucleotide therapy.

Eric Dane revealed he's been diagnosed with amyotrophic lateral sclerosis, also known as ALS. Here's what to know about the rare disease.

PrimeC has demonstrated promising results in the 18-month Phase 2b trial, with data highlighting its potential as a disease-modifying therapy for ALS. The trial revealed a marked reduction in ALS ...

Verge Genomics will use digital biomarkers to assess short-term disease progression in an ALS trial testing its VRG50635 ...

The trial will explore the ALS biomarkers, including the change from baseline in levels of neurofilament light chain.

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing pioneering RNA-based medicines, today announced that the final, positive results from the Investigator-Initiated ...

A natural antioxidant found in foods like kale and berries, kaempferol, may help protect nerve cells and shows promise as a ...

Neurofilaments light chain (NfL), a biomarker for neuronal damage with increasing prominence in the evaluation of ALS studies, was measured before and after treatment. Six participants had blood ...